SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-315424
Filing Date
2022-12-30
Accepted
2022-12-30 16:08:32
Documents
7
Effectiveness Date
2022-12-30

Document Format Files

Seq Description Document Type Size
1 S-8 d438621ds8.htm S-8 58822
2 EX-5.1 d438621dex51.htm EX-5.1 12172
3 EX-23.1 d438621dex231.htm EX-23.1 1872
4 EX-99.1 d438621dex991.htm EX-99.1 82456
5 EX-FILING FEES d438621dexfilingfees.htm EX-FILING FEES 15667
6 GRAPHIC g438621g1223091505997.jpg GRAPHIC 1785
7 GRAPHIC g438621g1223092216495.jpg GRAPHIC 2373
  Complete submission text file 0001193125-22-315424.txt   178099
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269081 | Film No.: 221502071
SIC: 2834 Pharmaceutical Preparations